Evaluation of Filariasis "MDP" Implementation on Changing Aspects of Knowledge, Environment, and Behavior of Filariasis Sufferers
Filariasis is an infectious disease caused by filarial worms and transmitted by mosquitoes. Efforts to suppress the case of filariasis are eliminated through the administration of filariasis Mass Drug Prevention (MDP). The filariasis MDP program in Ende Regency has been conducted since 2011-2015, and the first phase evaluation was conducted in 2017. This study aims to find a picture of community knowledge about the filariasis elimination program in Ende Regency, to find a picture of behavioral change and environmental management after the implementation of the filariasis elimination program. This research is qualitative research with an ethnographic approach. There were 20 informants consisting of 10 sufferers, 5 patients' families, 3 health workers, and 2 village officials. The results showed that almost all informants had known the Filariasis MDP program and had taken the filariasis drug. Most informants still had behaviors that were at risk of filariasis. The environment where the informant lives did not have a risk for filarial worm breeding. The conclusion of the research shows that the success in handling and preventing filariasis in Detusuko and Welamosa villages are supported by the community's understanding of the MDP program and consuming filariasis medicine, vanishing filarial mosquito breeding places. However, it was still found that community behavior has not changed which are activities outside the home at night, not using long-sleeved clothes and the habit of hanging dirty clothes.
Copyright (c) 2019 Jurnal Info Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright © 2013-2018 Jurnal Info Kesehatan Limited
Ownership of copyright
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by JURNAL INFO KESEHATAN and its licensors.
JURNAL INFO KESEHATAN grants to you a worldwide non-exclusive royalty-free revocable license to:
- view this website and the material on this website on a computer or mobile device via a web browser;
- copy and store this website and the material on this website in your web browser cache memory; and
- print pages from this website for your use.
- All articles published by JURNAL INFO KESEHATAN are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
JURNAL INFO KESEHATAN does not grant you any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or JURNAL INFO KESEHATAN prior written permission.
You may request permission to use the copyright materials on this website by writing to email@example.com.
Enforcement of copyright
JURNAL INFO KESEHATAN takes the protection of its copyright very seriously.
If JURNAL INFO KESEHATAN discovers that you have used its copyright materials in contravention of the license above, JURNAL INFO KESEHATAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of JURNAL INFO KESEHATAN copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org.
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com.